Dr. Ross is the director of the Virginia Institute of Neuropsychiatry and clinical
assistant professor at Virginia Commonwealth University (VCU). He completed medical school and residency in psychiatry at VCU. After that, he finished a fel owship in neuropsychiatry at the Maryland Psychiatric Research Center, University of Maryland, where he stayed on the faculty for several years. In
1997, he returned to VCU. In 2001, he founded the Virginia Institute of Neuropsychiatry, an organization dedicated to the understanding and treatment of patients with neuropsychiatric and general psychiatric disorders. He is a national y recognized clinician, educator and author. He specializes in treatment and research of patients with neuropsychiatric disorders, especial y traumatic brain injury, posttraumatic stress disorder and tardive dyskinesia.
Telephone: (804) 594-7046 (office), (866) 586-8977 (fax) E-Mail: [email protected] Website: www.VaNeuropsychiatry.org
Clinical Assistant Professor of Psychiatry
Virginia Commonwealth University - Medical Col ege of Virginia
2012: Consultant to the Virginia Board of Medicine, Richmond, VA, performing
case reviews pertaining to physicians licensed in Virginia.
2012: Member of Advisory Board of VCU Traumatic Brain Injury Model Systems
Consultant to American Health and Wel ness Institute, Verona, VA; and the
Georgia state psychiatric hospital system
Consultant to Lega F. D'Oro Research Center, Osimo, Italy. LDRC treated
children and adults with multiple disabilities, including deafness, blindness, physical disabilities, cognitive disabilities and behavioral disabilities.
Consultant to Hiram Davis Medical Center, Petersburg, VA. HDMC treated
patients who were dual y diagnosed with mental retardation and somatic medical disorder requiring skil ed, inpatient nursing care.
Medical Col ege of Virginia-Virginia Commonwealth University
Part-time psychiatric consultant to the Emergency Department and Inpatient
Fel owship in neuropsychiatry (July 1990 to June 1992)
Internship and residency in psychiatry (July 1986 to June 1990)
Undergraduate (1978-82): B.S. magna cum laude
1994 - present: Diplomate in psychiatry, American Board of Psychiatry and
11/30/10 – 11/29/20: Certified in the subspecialty of Behavioral Neurology &
Neuropsychiatry by the United Council for Neurologic Subspecialties Major career interests
Traumatic brain injury, movement disorders caused by psychiatric
medications (including parkinsonism and tardive dyskinesia), posttraumatic
stress disorder, sleep disorders, pain disorders, schizophrenia, bipolar disorder, depression, and anxiety. Major career activities
Clinical: treated and consulted on hundreds of patients in both public and
Teaching: Have given hundreds of oral and poster presentations on clinical
and research topics to audiences including patients, family members, students, clinicians and researchers. Venues have included clinics, hospitals, international conferences and university Grand Rounds, in the United States and Europe. Supervised the research and clinical work of research fel ows, graduate students, psychiatry residents and medical students.
Research: published 40 manuscripts, most of which were peer-reviewed;
awarded total of $425,000 for grants as principal investigator, and involved as sub-investigator on grants total ing several mil ion dol ars; reviewed manuscripts
for multiple journals; reviewed grants for NIH.
Expert consultation: extensive experience in forensic, disability and other
American Neuropsychiatric Association International Brain Injury Association
Brain Injury Association of Virginia American Psychiatric Association National Alliance for the Mental y Il Psychiatric Society of Virginia Richmond Association of Phi Beta Kappa
Young Scientist Award, given by the Biennial Winter Workshop on Schizophrenia.
McKee Jarboe Award, given to a young faculty member who has contributed to the understanding or treatment of chronic mental il ness.
Stanley Award, given for showing promise as young psychiatric
Young Investigator Award, given by the International Congress on Schizophrenia Research.
Chi Beta Phi honorary scientific fraternity (president).
Most Outstanding Freshman Chemistry Student.
1978-82 Allan Scholarship (ful scholarship given to the best students based on
Reviewed manuscripts for the fol owing journals: • American Journal of Psychiatry • Biological Psychiatry • Brain Injury • Journal of Neuropsychiatry and Clinical Neurosciences • Neurotoxicology and Teratology • Psychiatry Research • Psychophysiology • Schizophrenia Bul etin
Neuroleptics in Schizophrenia Outpatient Smokers: The Effects of Olanzapine
and Risperidone on Smoking Behavior, Co-PI's - A.K. Pandurangi, D.E. Ross, Lilly 4/15/99-10/14/00, $248,000.
Eye Tracking Disorder and Genetics in Schizophrenia, PI - D.E. Ross, NARSAD
Eye Tracking Disorder in Relatives of Patients with Schizophrenia, PI - D.E.
Ross, A.D. Wil iams Program, Medical Col ege of Virginia, Virginia
Commonwealth University, 7/1/98-6/30/99, $10,000.
Functional Neuroanatomy of Eye Tracking Disorder in Normal Controls, PI- D.E.
Ross, NIH (Seed money grant from a CRC grant, PI-W.T. Carpenter) 8/1/97-7/31/98 $5,800.
Optokinetic eye movements in schizophrenia, PI - D.E. Ross, NIH 3/1/97-2/28/98
Functional Neuroanatomy of Eye Tracking Disorder in Schizophrenia, PI- D.E.
Ross, University of Maryland at Baltimore, 7/1/96-6/30/97 $14,928.
Prevalence of Schizophrenia Spectrum Disorders in Relatives of Schizophrenic
Patients with and without the Deficit Syndrome, PI - D.E. Ross, NIH (Seed money grant from a CRC grant, PI-W.T. Carpenter) 6/1/96-5/31/97 $4,992.
PET Study of Eye Tracking Disorder in Schizophrenia, PI - D.E. Ross, NIH (Seed
money grant from a CRC grant, PI-W.T. Carpenter) 7/1/95-6/30/96 $9,942.
Eye Tracking Disorder and the Deficit Syndrome of Schizophrenia, PI - D.E.
Ross, NIH (Seed money grant from a CRC grant, PI- W.T. Carpenter) 5/1/94-
Classification and Course of the Schizophrenias, PI - W.T. Carpenter, NIH
8/1/93-7/31/98 $5,234,144 Young Investigator salary support.
Familial Schizophrenia Spectrum Personality Disorders, PI - G.K. Thaker, NIH
5/1/93-4/30/97 $383,347, 10% Salary support.
Specification of Abnormal Eye Movements in Schizophrenic Patients, PI - D.E.
Ross, Scottish Rite, 8/1/92-7/31/94 $69,000, 30% Salary support.
Grant review work
1997-98: Ad hoc reviewer for National Institute of Mental Health, Clinical Pharmaceutical company relationships
2000, 2006 - 2008: Company: AstraZeneca. Product: quetiapine (Seroquel®).
2004 - 2007: Company: Forest Pharmaceuticals. Products: memantine
(Namenda®) and escitalopram (Lexapro®). Relationships: Speaker’s bureau; consultant.
2005: Company: Cephalon. Products: modafinil (Provigil®). Relationships:
2000 - 2004: Company: Eli Lil y and Company. Product: olanzapine
(Zyprexa®). Relationships: Speaker’s bureau; consultant; educational grants.
Publications: 52 total; all were reviewed by an independent editor; all but five
were peer-reviewed. • Statistics per Google Scholar
(http://scholar.google.com/citations?user=Q6UYdlYAAAAJ) o Citations: 1446
§ Per Wikipedia, the h index is a measure of academic productivity,
combining number of publications and number of citations per publication. An h index of 19 indicates that 19 of the below cited publications have been cited at least 19 times each. Wikipedia reported that “…a value for h of about 12 might be typical for advancement to tenure (associate professor) at major research universities. A value of about 18 could mean a full professorship….” Comparative values for physicians working in
private practice settings are unavailable but would be expected to
be less than those of ful -time academicians.
Ross, D. E., A. L. Ochs, M. E. DeSmit, J. M. Seabaugh, M. D. Havranek (in
press). Man vs. Machine Part 2: Comparison of radiologists’ interpretations and NeuroQuant® measures of brain asymmetry and progressive atrophy in patients with traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences.
Ross, D. E., C. Castelvecchi, A. L. Ochs (2013). Brain MRI volumetry in a single
patient with mild traumatic brain injury. Brain Injury 27:634-636.
Ross, D. E., A. L. Ochs, J. M. Seabaugh, C. R. Shrader (2013). Man vs.
machine: Comparison of radiologists’ interpretations and NeuroQuant® volumetric analyses of brain MRIs in patients with traumatic brain injury.
Journal of Neuropsychiatry and Clinical Neurosciences 25:1-8.
Ross, D. E., T. J. Graham, A. L. Ochs (2013). Review of the evidence supporting
the medical and forensic use of NeuroQuant® in patients with traumatic brain injury. Psychological Injury and the Law 6:75-80.
Ross, D. E. (September 29, 2012). New advances help detect brain injuries
(Correspondent of the Day -- Letter to the Editor). Richmond Times Dispatch.
Ross, D. E., A. L. Ochs, J. M. Seabaugh, M. F. DeMark, C. R. Shrader, J. H.
Marwitz, M. D. Havranek (2012). Progressive brain atrophy in patients with
chronic neuropsychiatric symptoms after mild traumatic brain injury: A preliminary study. Brain Injury 26:1500-9.
Ross DE, Ochs AL, Seabaugh J, Henshaw T (2012): NeuroQuant® revealed
hippocampal atrophy in a patient with traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences 24: E33.
Ross DE (2011): Review of longitudinal studies of MRI brain volumetry in
patients with traumatic brain injury. Brain Injury 25:1271-8.
Ross DE (2009): High tech does not mean high quality. Richmond Times Dispatch 03/08/09, section A, p. 9.
Ross DE, Clevinger LE (2008): Managing more than medications. Brain Injury
Hettema JM, Ross DE (2007): A case of aripiprazole-related tardive akathisia
and its treatment with ropinirole (letter). J Clin Psychiatry 68:1814-1815.
Ross, DE (2005): Methodological concerns in a trial of ziprasidone and
olanzapine (letter). Am J Psychiatry 262:1391.
Ross, DE (2005): Tardive dyskinesia and second-generation antipsychotics
(letter). Am J Psychiatry 162:405.
Ross DE, Thomas M, Booth M, Weinborn M (2005): Rate of tardive dyskinesia in
hospitalized patients (letter). Am J Psychiatry 162:816.
Messias E, Kirkpatrick B, Bromet E, Ross D, Buchanan RW, Carpenter WT Jr,
Tek C, Kendler KS, Walsh D (2004): Summer birth and deficit schizophrenia: A pooled analysis from six countries. Arch Gen Psychiatry 61:985-989.
Ross, DE (2004): Clozapine and typical antipsychotics (letter). Am J Psychiatry
Ross DE (2004): Ziprasidone and mania (letter). Am J Psychiatry 161:1503. Ross DE (2003): Improving the DSM Axis System (letter). Psychiatric News
Thaker GK, Avila MT, Hong EL, Medoff DR, Ross DE, Adami HM (2003): A
model of smooth pursuit eye movement deficit associated with the schizophrenia phenotype. Psychophysiology 40:277-84.
Ross DE (2003): Psychiatry and neurology. Am J Psychiatry 160:596.
Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr WT (2001): In reply:
Distinguishing simple schizophrenia and the deficit syndrome of schizophrenia. Arch Gen Psychiatry, in press.
Ross DE, Hasnain M, Pandurangi AK (2001): Subspecialty training in
schizophrenia may lead to improved treatment for treatment-resistant patients. Psychiatric Services 52:240.
Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr WT (2001): A separate
disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165-171.
Ross DE, Kirkpatrick B, Karkowski LM, Straub RE, MacLean CJ, O'Neil A,
Compton AD, Murphy B, Walsh D, Kendler KS (2000): Sibling correlation of deficit syndrome in the Irish study of high-density schizophrenia families. Am J Psychiatry 157:1071-6.
Ross DE (2000): The deficit syndrome and eye tracking disorder may reflect a
distinct subtype within the syndrome of schizophrenia. Schizophr Bul 26:855-66.
Ross DE (2000): Update on movement disorders caused by antipsychotic
medications. Psychiatric Society of Virginia News Summer:3,8.
Kirkpatrick B, Ross DE, Walsh D, Karkowski L, Kendler KS (2000): Family
characteristics of deficit and nondeficit schizophrenia in the Roscommon Family Study. Schizophr Res 45:57-64.
Ross DE (2000): New hope for consumers with movement disorders caused by
antipsychotic medications. The Network 16:6.
Ross DE (2000): A method for developing a biopsychosocial formulation. Journal of Child and Family Studies 9:1-6.
Thaker GK, Ross DE, Cassady SL, Adami HM, Medoff DR, Sherr J (2000):
Saccadic eye movement abnormalities in relatives of patients with schizophrenia. Schizophr Res 45:235-44.
Thaker GK, Ross DE, Buchanan RW, Adami HM, Medoff DR (1999): Smooth
pursuit eye movements to extraretinal motion signals: deficits in patients
with schizophrenia. Psychiatry Res 88:209-19.
Kunkel R, Adami H, Zetlmeisl M, Ross D, Thaker G (1998): Recruitment of non-
patient volunteers with schizophrenia spectrum personality symptoms. Schizophr Res 34:181-186.
Ross DE, Buchanan RW, Thaker GK, Medoff DR, Lahti AC (1998): Association
between eye tracking disorder in schizophrenia and poor sensory integration. Am J Psychiatry 155:1352-1357.
Thaker GK, Ross DE, Cassady SL, Adami HM, LaPorte D, Medoff DR, Lahti A
(1998): Smooth pursuit eye movements to extraretinal motion signals: deficits in relatives of patients with schizophrenia. Arch Gen Psychiatry 55:830-836.
Ross DE, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Compton AD, Thaker
GK (1998): The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia. Schizophr Res 31:141-150.
Hashimoto T, Ross DE, Gao X, Medoff DR, Tamminga CA (1998): Mixture in the
distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia. Psychopharmacology 137:107-112.
Ross DE, Thaker GK, Buchanan RW, Lahti AC, Conley R, Medoff D (1998):
Specific measures account for most of the variance in qualitative ratings of
smooth pursuit eye movements in schizophrenia. Arch Gen Psychiatry 55:184-185.
Kirkpatrick B, Ross DE (1997): The trap of protopathic bias in neuropsychiatric
research. Biol Psychiatry 41:257-8.
Ross DE (1997): Grey matter correlates of syndromes in schizophrenia. Br J
Ross DE, Carpenter Jr WT (1997): Negative symptoms in schizophrenia. The Journal of the California Alliance for the Mental y Il 8:81-83.
Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, Bartko
JJ, Goodman J, Tien AY (1997): Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the
deficit syndrome. Biol Psychiatry 42:781-796.
Kim CE, Thaker GK, Ross DE, Moran MJ (1997): Accuracies of saccades to
moving targets: During pursuit initiation and maintenance. Experimental Brain Research 113:371-377.
Moran MJ, Thaker GK, LaPorte DJ, Cassady SL, Ross DE (1996): Covert visual
attention in schizophrenia spectrum personality disordered subjects: Visuospatial cuing and alerting effects. J Psychiatr Res 4:261-275.
Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M,
Hartley J (1996): Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. Am J Psychiatry
Thaker GK, Ross DE, Moran MJ, Lahti A, Buchanan R, Ellsberry RL (1996):
Does pursuit abnormality in schizophrenia represent a deficit in the predictive
mechanism? Psychiatry Res 59:221-237.
Tien AY, Ross DE, Pearlson G, Strauss ME (1996): Eye movements and
psychopathology in schizophrenia and bipolar disorder. Journal of Nervous and Mental Diseases 184:331-338.
Ross DE, Ochs AL, Pandurangi AK, Thacker LR, Kendler KS (1996): Mixture
analysis of smooth pursuit eye movements in schizophrenia. Psychophysiology 33:390-397.
Thaker G, Cassady S, Adami H, Moran M, Ross D (1996): Eye movements in
spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients. Am J Psychiatry 153:362-368.
Ross DE, Thaker GK, Holcomb HH, Cascel a NG, Medoff DR, Tamminga CA
(1995): Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions. Psychiatry Res 58:53-67.
Dixon L, Thaker GK, Conley R, Ross DE, Cascel a N, Tamminga CA (1993):
Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a
double-blind design. Schizophr Res 10:267-271.
Kendler K, Ochs A, Gorman A, Hewitt J, Ross D, Mirsky A (1991): The structure
of schizotypy: a pilot multitrait twin study. Psychiatry Res 36:19-36.
Ross DE, Ochs AL, Hil MP, Goldberg SC, Pandurangi AK, Winfrey J (1988): The
erratic nature of eye movements in schizophrenic patients as revealed by high resolution techniques. Biol Psychiatry 24:675-688.
Selected recent presentations
Ross DE (May 3, 2013): (invited speaker) Update on Neuropsychiatry and
Traumatic Brain Injury. Wil iamsburg Annual Conference on Traumatic Brain Injury, Wil iamsburg, VA.
Ross DE (March 15, 2013): (invited speaker) Using Neuroimaging Tests on the
Brain to Detect Areas of Damage and Determining Admissibility Under Daubert/Frye. Brain Injury Claims & Litigation, American Conference Institute’s 2nd Annual Summit for Med Mal and Other Personal Injury Leaders, Philadelphia, PA.
Ross DE (September 28, 2012): (invited speaker) Update on MRI and Mild
Traumatic Brain Injury. Grand Rounds, Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond, VA.
Ross DE (April 18, 2012): (invited speaker) Update on NeuroQuant®: A
Breakthrough Method for Detecting MRI Brain Atrophy in Patients with Traumatic Brain Injury. Neuropsychology and Rehabilitation Psychology Rounds, Richmond, VA.
Ross DE (March 30, 2012): (invited speaker) An update on NeuroQuant® in
traumatic brain injury. American Conference Institute Brain Injury Litigation Conference, Philadelphia, PA.
Ross DE, Jones RT (March 10, 2012): (invited speaker) Traumatic Brain Injury
and Posttraumatic Stress Disorder. Brain Injury Association of Virginia, Richmond, VA.
Ross DE, Ochs AL, Havranek M (September 2011): Update on NeuroQuant®.
NABIS Ninth Annual Conference on Brain Injury, New Orleans, LA.
Ochs AL, Ross DE (2011): Artefacts affecting NeuroQuant automated measures
of brain MRI volumes. Journal of Head Trauma Rehabilitation 26: 414-415.
Ross DE, Ochs AL, Seabaugh JS, Henshaw T (June 2011): MRI Brain
Volumetry Reveals Atrophy and Asymmetry in Patients with Traumatic Brain Injury. Federal Interagency Conference on TBI, Washington, D.C.
Ross DE, Ochs AL, Seabaugh JS, Henshaw T (May 2011): Brain MRI Volume in
Traumatic Brain Injury: Clinical and Forensic Applications. Wil iamsburg Annual Conference on Traumatic Brain Injury, Wil iamsburg, VA.
Ross DE, Ochs AL, Seabaugh JS, Henshaw T (presented on March 24, 2011):
A Case Report of Smal Hippocampi in a Patient with Mild Traumatic Brain Injury. Annual Meeting of the American Neuropsychiatric Association, Denver, CO.
Ross DE (June 4, 2009): Neuropsychiatry of traumatic brain injury in 2009.
Wil iamsburg Annual Conference on Traumatic Brain Injury, Wil iamsburg, VA.
Ross DE (April 21, 2008): Neuropsychiatric Medications and Traumatic Brain
Injury. Meeting of the Brain Injury Assocation of Virginia, Richmond, VA.
Ross DE (December 14, 2007): Neuropsychiatric Medications and Traumatic
Brain Injury. Lecture to the physiatry residents at Virginia Commonwealth University, Richmond, VA.
Ross DE (March 2006): Neuropsychiatry and Traumatic Brain Injury. Lecture to the Neuropsychology division of the Department of Rehabilitation Medicine at Virginia Commonwealth University, Richmond, VA.
Ross DE (2008 to present): Neuropsychiatry and Traumatic Brain Injury. Annual lecture to the psychiatry residents at Virginia Commonwealth University, Richmond, VA.
Ross DE (1998 to present): Tardive Dyskinesia and Other Movement Disorders
in Neuropsychiatry. Annual lecture to the psychiatry residents at Virginia Commonwealth University, Richmond, VA.
THE LEGAL ASPECTS OF EQUINE RACING CHEMISTRY . The definition of a prohibited substance . Evidence of a prohibited substance . Racing laboratories in Australia and New Zealand . High-performance liquid chromatography (HPLC) . Gas chromatography-mass spectrometry (GCMS) . Confirmation of the identity of drugs . The use of thresholds for certain compounds. Thresholds for therapeutic substa